Cure Sleep Apnea Without Cpap

Natural Solution to get rid of Sleep Apnea

Get Instant Access

Abbate, F., Supuran, C.T., Scozzafava, A., Orioli, P., Stubbs, M.T. and Klebe, G. (2002) Nonaromatic sulfonamide group as an ideal anchor for potent human carbonic anhy-drase inhibitors: Role of hydrogen-bonding networks in ligand binding and drug design. Journal of Medicinal Chemistry 45, 3583-3587.

Antel, J. (1999) Integration of combinatorial chemistry and structure-based drug design. Current Opinion in Drug Discovery and Development 2, 224-233.

Aribi, A.M., and Stringer, J.L. (2002) Effects of antiepileptic drugs on extracellular pH regulation in the hippocampal CA1 region in vivo. Epilepsy Research 49, 143-151.

Babine, R.E., and Bender, S.L. (1997) Molecular recognition of protein-ligand complexes: Applications to drug design. Chemical Reviews 97, 1359-1472.

Baldwin, J.J., Ponticello, G.S., Anderson, P.S., Christy, M.E., Murcko, M.A., Randall, W.C., Schwam, H., Sugrue, M.F., Springer, J.P., Gautheron, P. et al. (1989) Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma. Journal of Medicinal Chemistry 32, 2510-2513.

Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N., and Bourne, P.E. (2000) The protein data bank. Nucleic Acids Research 28, 235-242.

Böhm, H.J., and Klebe, G. (1996) What can we learn from molecular recognition in pro-tein-ligand complexes for the design of new drugs? Angewandte Chemie International Edition in English 35, 2588-2614.

Böhm, H.J., Klebe, G., and Kubinyi, H. (1996) Wirkstoffdesign, Spektrum Akademischer Verlag, Heidelberg, Berlin, Oxford.

Bohm, H.J., and Stahl, M. (2000) Structure-based library design: molecular modelling merges with combinatorial chemistry. Current Opinion in Chemical Biology 4, 283-286.

Breton, S. (2001) The cellular physiology of carbonic anhydrases. Journal of Pancreas (Online) 2, 159-164.

Busenbark, K., Pahwa, R., Hubble, J., and Koller, W. (1992) The effect of acetazolamide on essential tremor: an open-label trial. Neurology 42, 1394-1395.

Carrion, E., Hertzog, J.H., Medlock, M.D., Hauser, G.J., and Dalton, H.J. (2001) Use of acetazolamide to decrease cerebrospinal fluid production in chronically ventilated patients with ventriculopleural shunts. Archives of Disease of the Child 84, 68-71.

Casini, A., Antel, J., Abbate, F., Scozzafava, A., David, S., Waldeck, H., Schafer, S., and Supuran, C.T. (2003) Carbonic anhydrase inhibitors: SAR and x-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV. Bioorganic and Medicinal Chemistry Letters 13, 841-845.

Casini, A., Scozzafava, A., Mastrolorenzo, A., and Supuran, L.T. (2002) Sulfonamides and sulfonylated derivatives as anticancer agents. Current Cancer Drug Targets 2, 55-75.

Chazalette, C., Riviere-Baudet, M., Scozzafava, A., Abbate, F., Ben Maarouf, Z., and Supuran, C.T. (2001) Carbonic anhydrase inhibitors, interaction of boron derivatives with isozymes I and II: A new binding site for hydrophobic inhibitors at the entrance of the active site as shown by docking studies. Journal of Enzyme Inhibition 16, 125-133.

Christianson, D.W., and Cox, J.D. (1999) Catalysis by metal-activated hydroxide in zinc and manganese metalloenzymes. Annual Reviews in Biochemistry 68, 33-57.

Cowen, M.A., Green, M., Bertollo, D.N., and Abbott, K. (1997) A treatment for tardive dyskinesia and some other extrapyramidal symptoms. Journal of Clinical Psycho-pharmacology 17, 190-193.

Cox, J.D., Hunt, J.A., Compher, K.M., Fierke, C.A., and Christianson, D.W. (2000) Structural influence of hydrophobic core residues on metal binding and specificity in carbonic anhydrase II. Biochemistry 39, 13687-13694.

Cramer, R.D., III, Patterson, D.E., and Bunce, J.D. (1989) Recent advances in comparative molecular field analysis (CoMFA). Progress in Clinical and Biological Research 291, 161-165.

DeLano, W.L. (2002) The PyMol molecular graphics system, DeLano Scientific, San Carlos, CA, USA.

DesJarlais, R.L., Sheridan, R.P., Seibel, G.L., Dixon, J.S., Kuntz, I.D., and Venkataraghavan, R. (1988) Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure. Journal of Medicinal Chemistry 31, 722-729.

Dodgson, S.J., Shank, R.P., and Maryanoff, B.E. (2000) Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 41, S35-S39.

Duda, D., Govindasamy, L., Agbandje-McKenna, M., Tu, C., Silverman, D.N., and McKenna, R. (2003) The refined atomic structure of carbonic anhydrase II at 1.05 A resolution: implications of chemical rescue of proton transfer. Acta Crystallografica D Biological Crystallography 59, 93-104.

Duda, D., Tu, C., Qian, M., Laipis, P., Agbandje-McKenna, M., Silverman, D.N., and McKenna, R. (2001) Structural and kinetic analysis of the chemical rescue of the proton transfer function of carbonic anhydrase II. Biochemistry 40, 1741-1748.

Erdei, A., Gyori, I., Gedeon, A., and Szabo, I. (1990) Successful treatment of intractable gastric ulcers with acetazolamide. Acta Medica Hungarica 47, 171-178.

Esposito, E.X., Baran, K., Kelly, K., and Madura, J.D. (2000) Docking of sulfonamides to carbonic anhydrase II and IV. Journal of Molecular Graph Model 18, 283-289, 307-288.

Fakhoury, T., Murray, L., Seger, D., McLean, M., and Abou-Khalil, B. (2002) Topiramate overdose: Clinical and laboratory features. Epilepsy Behavior 3, 185-189.

Gibbs, J.W., III, Sombati, S., DeLorenzo, R.J., and Coulter, D.A. (2000) Cellular actions of topiramate: Blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 41, S10-S16.

Gohlke, H., Hendlich, M., and Klebe, G. (2000a) Knowledge-based scoring function to predict protein-ligand interactions. Journal of Molecular Biology 295, 337-356.

Gohlke, H., Hendlich, M., and Klebe, G. (2000b) Predicting binding modes, binding affinities and 'hot spots' for protein-ligand complexes using a knowledge-based scoring function. Perspectives in Drug Discovery and Design 20, 115-144.

Goodsell, D.S., and Olson, A. J. (1990) Automated docking of substrates to proteins by simulated annealing. Proteins 8, 195-202.

Greer, J., Erickson, J.W., Baldwin, J.J., and Varney, M.D. (1994) Application of the three-dimensional structures of protein target molecules in structure-based drug design. Journal of Medicinal Chemistry 37, 1035-1054.

Gruneberg, S., Stubbs, M.T., and Klebe, G. (2002) Successful virtual screening for novel inhibitors of human carbonic anhydrase: strategy and experimental confirmation. Journal of Medicinal Chemistry 45, 3588-3602.

Grzybowski, B.A., Ishchenko, A.V., Kim, C.Y., Topalov, G., Chapman, R., Christianson, D.W., Whitesides, G.M., and Shakhnovich, E.I. (2002a) Combinatorial computational method gives new picomolar ligands for a known enzyme. Proceedings of the National Academy of Sciences of the United States of America 99, 1270-1273.

Grzybowski, B.A., Ishchenko, A.V., Shimada, J., and Shakhnovich, E.I. (2002b) From knowledge-based potentials to combinatorial lead design in silico. Accounts of Chemical Research 35, 261-269.

Gunther, J., Bergner, A., Hendlich, M., and Klebe, G. (2003) Utilising structural knowledge in drug design strategies: applications using Relibase. Journal of Molecular Biology 326, 621-636.

Hansch, C., and Fujita, T. (1964) r-s-p analysis: A method for the correlation of biological activity and chemical structure. Journal of the American Chemical Society 86, 1616-1626.

Hansch, C., McClarin, J., Klein, T., and Langridge, R. (1985) A quantitative structure-activity relationship and molecular graphics study of carbonic anhydrase inhibitors. Molecular Pharmacology 27, 493-498.

Hebebrand, J., Antel, J., Preuschoff, U., David, S., Sann, H., and Weske, M., (2002) Drug screening method for the treatment and prophylaxis of obesity. WO Patent 02/07821.

Hendlich, M., Bergner, A., Gunther, J., and Klebe, G. (2003) Relibase: Design and development of a database for comprehensive analysis of protein-ligand interactions. Journal of Molecular Biology 326, 607-620.

Herrero, A. I., Del Olmo, N., Gonzalez-Escalada, J. R., and Solis, J. M. (2002) Two new actions of topiramate: inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductance. Neuropharmacology 42, 210-220.

Hindle, S.A., Rarey, M., Buning, C., and Lengauer, T. (2002) Flexible docking under phar-macophore type constraints. Journal of Computer Aided Molecular Design 16, 129-149.

Hunt, C.A., Mallorga, P.J., Michelson, S. R., Schwam, H., Sondey, J. M., Smith, R.L., Sugrue, M.F., and Shepard, K.L. (1994) 3-Substituted thieno[2,3-b][1,4]thiazine-6-sulfona-mides. A novel class of topically active carbonic anhydrase inhibitors. Journal of Medicinal Chemistry, 37, 240-247.

Inoue, Y., Takata, K., Sakamoto, I., Hazama, H., and Kawahara, R. (1999) Clinical efficacy and indication of acetazolamide treatment on sleep apnea syndrome. Psychiatry and Clinical Neuroscience 53, 321-322.

Jones, P.W., and Greenstone, M. (2001) Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease. Cochrane Database System Reviews 1, CD002881.

Kim, C.Y., Whittington, D.A., Chang, J.S., Liao, J., May, J.A., and Christianson, D.W. (2002) Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IV. Journal of Medicinal Chemistry 45, 888-893.

Klebe, G. (2000) Recent developments in structure-based drug design. Journal of Molecular Medicine 78, 269-281.

Klebe, G. (2003) From structure to recognition principles: Mining in crystal data as a prerequisite for drug design. Ernst Schering Research Foundation Workshop 42, 103-126.

Klebe, G., and Abraham, U. (1993) On the prediction of binding properties of drug molecules by comparative molecular field analysis. Journal of Medicinal Chemistry, 36, 70-80.

Klebe, G., Abraham, U., and Mietzner, T. (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. Journal of Medicinal Chemistry 37, 4130-4146.

Koller, W.C., Hristova, A., and Brin, M. (2000) Pharmacologic treatment of essential tremor. Neurology 54, S30-S38.

Kubinyi, H. (1998) Structure-based design of enzyme inhibitors and receptor ligands. Current Opinion in Drug Discovery and Development 1, 4-15.

Kubinyi, H. (1999) Chance favors the prepared mind: From serendipity to rational drug design. Journal of Receptor and Signal Transduction Research 19, 15-39.

Kuo, R.L., Moran, M.E., Kim, D.H., Abrahams, H.M., White, M.D., and Lingeman, J.E. (2002) Topiramate-induced nephrolithiasis. Journal of Endourology 16, 229-231.

Kuzniecky, R., Ho, S., Pan, J., Martin, R., Gilliam, F., Faught, E., and Hetherington, H. (2002) Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology 58, 368-372.

Leniger, T., Wiemann, M., Bingmann, D., Widman, G., Hufnagel, A. and Bonnet, U. (2002) Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons. Epilepsia 43, 469-474.

Liljas, A., Hakansson, K., Jonsson, B.H., and Xue, Y. (1994) Inhibition and catalysis of carbonic anhydrase: Recent crystallographic analyses. European Journal of Biochemistry 219, 1-10.

Lindskog, S. (1997) Structure and mechanism of carbonic anhydrase. Pharmacology and Therapeutics 74, 1-20.

Martens-Lobenhoffer, J., and Banditt, P. (2002) Clinical pharmacokinetics of dorzolamide. Clinical Pharmacokinetics 41, 197-205.

Martinelli, R.A., Hanson, G.R., Thompson, J.S., Holmquist, B., Pilbrow, J.R., Auld, D.S., and Vallee, B.L. (1989) Characterization of the inhibitor complexes of cobalt carboxypepti-dase A by electron paramagnetic resonance spectroscopy. Biochemistry 28, 2251-2258.

Maryanoff, B.E., Costanzo, M.J., Nortey, S.O., Greco, M.N., Shank, R.P., Schupsky, J.J., Ortegon, M.P., and Vaught, J.L. (1998) Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives. Journal of Medicinal Chemistry 41, 1315-1343.

Maryanoff, B.E., Nortey, S.O., Gardocki, J.F., Shank, R.P., and Dodgson, S.P. (1987) Anticonvulsant O-alkyl sulfamates. 2,3:4,5-Bis-O-(1-methylethylidene)- beta-D-fructopy-ranose sulfamate and related compounds. Journal of Medicinal Chemistry 30, 880-887.

Masereel, B., Rolin, S., Abbate, F., Scozzafava, A., and Supuran, C.T. (2002) Carbonic anhydrase inhibitors: Anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties. Journal of Medicinal Chemistry 45, 312-320.

Matter, H., Kotsonis, P., Klingler, O., Strobel, H., Frohlich, L.G., Frey, A., Pfleiderer, W., and Schmidt, H.H. (2002) Structural requirements for inhibition of the neuronal nitric oxide synthase (NOS-I): 3D-QSAR analysis of 4-oxo- and 4-amino-pteridine-based inhibitors. Journal of Medicinal Chemistry 45, 2923-2941.

McLean, M.J., Bukhari, A.A., and Wamil, A.W. (2000) Effects of topiramate on sodium-dependent action-potential firing by mouse spinal cord neurons in cell culture. Epilepsia 41, S21-S24.

Miner, M.E. (1986) Acetazolamide treatment of progressive hydrocephalus secondary to intraventricular hemorrhage in a preterm infant. Childs Nervous System 2, 105-106.

Morris, G.M., Goodsell, D.S., Halliday, R.S., Huey, R., Hart, W.E., Belew, R.K., and Olson, A.J. (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry 19, 1639-1662.

Morris, G.M., Goodsell, D.S., Huey, R., and Olson, A. J. (1996) Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4. Journal of Computer Aided Molecular Design 10, 293-304.

Olive, P.L., Aquino-Parsons, C., MacPhail, S.H., Liao, S.Y., Raleigh, J.A., Lerman, M.I., and Stanbridge, E.J. (2001) Carbonic anhydrase IX as an endogenous marker for hypoxic cells in cervical cancer. Cancer Research 61, 8924-8929.

Osterman, P.O., Askmark, H., and Wistrand, P.J. (1985) Serum carbonic anhydrase III in neuromuscular disorders and in healthy persons after a long-distance run. Journal of Neurological Science 70, 347-357.

Pajeva, I., and Wiese, M. (1998) Molecular modeling of phenothiazines and related drugs as multidrug resistance modifiers: a comparative molecular field analysis study. Journal of Medicinal Chemistry 41, 1815-1826.

Pavone, V., De Simone, G., Nastri, F., Galdiero, S., Staiano, N., Lombardi, A., and Pedone, C. (1998) Multiple binding mode of reversible synthetic thrombin inhibitors: A comparative structural analysis. Biological Chemistry 379, 987-1006.

Perucca, E. (1997) A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacological Research 35, 241-256.

Philippi, H., Bieber, I., and Reitter, B. (2001) Acetazolamide treatment for infantile central sleep apnea. Journal of Child Neurology 16, 600-603.

Pickens, J. C., Merritt, E. A., Ahn, M., Verlinde, C. L., Hol, W. G., and Fan, E. (2002) Anchor-based design of improved cholera toxin and E. coli heat-labile enterotoxin receptor binding antagonists that display multiple binding modes. Chemical Biology 9, 215-224.

Pickkers, P., Hughes, A.D., Russel, F.G., Thien, T., and Smits, P. (2001) In vivo evidence for K(Ca) channel opening properties of acetazolamide in the human vasculature. British Journal of Pharmacology 132, 443-450.

Preisig, P.A., Toto, R.D., and Alpern, R.J. (1987) Carbonic anhydrase inhibitors. Renal Physiology 10, 136-159.

Puscas, I. (1984) Treatment of gastroduodenal ulcers with carbonic anhydrase inhibitors. Annals of the New York Academy of Science 429, 587-591.

Recacha, R., Costanzo, M.J., Maryanoff, B.E., and Chattopadhyay, D. (2002) Crystal structure of human carbonic anhydrase II complexed with an anti-convulsant sugar sulphamate. Biochemical Journal 361, 437-441.

Reis, J., Tergau, F., Hamer, H.M., Muller, H.H., Knake, S., Fritsch, B., Oertel, W.H., and Rosenow, F. (2002) Topiramate selectively decreases intracortical excitability in human motor cortex. Epilepsia 43, 1149-1156.

Ribacoba Montero, R., and Salas Puig, X. (2002) Efficacy and tolerability of long term topiramate in drug resistant epilepsy in adults. Reviews in Neurology 34, 101-105.

Rosenfeld, W.E. (1997) Topiramate: A review of preclinical, pharmacokinetic, and clinical data. Clinical Therapy 19, 1294-1308.

Rotstein, S.H., and Murcko, M.A. (1993a) GenStar: a method for de novo drug design. Journal of Computer Aided Molecular Design 7, 23-43.

Rotstein, S.H., and Murcko, M.A. (1993b) GroupBuild: a fragment-based method for de novo drug design. Journal of Medicinal Chemistry 36, 1700-1710.

Seely, J.F., and Dirks, J.H. (1977) Site of action of diuretic drugs. Kidney International 11, 1-8.

Shank, R.P., Gardocki, J.F., Streeter, A.J., and Maryanoff, B.E. (2000) An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia, 41, S3-S9.

Shank, R.P., Gardocki, J.F., Vaught, J.L., Davis, C.B., Schupsky, J.J., Raffa, R. B., Dodgson, S.J., Nortey, S.O., and Maryanoff, B.E. (1994) Topiramate: preclinical evaluation of structurally novel anticonvulsant. Epilepsia 35, 450-460.

Sills, G.J., Leach, J.P., Kilpatrick, W.S., Fraser, C.M., Thompson, G.G., and Brodie, M.J. (2000) Concentration-effect studies with topiramate on selected enzymes and intermediates of the GABA shunt. Epilepsia 41, S30-S34.

Skradski, S., and White, H.S. (2000) Topiramate blocks kainate-evoked cobalt influx into cultured neurons. Epilepsia 41, S45-S47.

Smith, G.M., Alexander, R.S., Christianson, D.W., McKeever, B.M., Ponticello, G.S., Springer, J.P., Randall, W.C., Baldwin, J.J., and Habecker, C.N. (1994) Positions of His-64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitors. Protein Science 3, 118-125.

Sotriffer, C.A., Gohlke, H., and Klebe, G. (2002) Docking into knowledge-based potential fields: A comparative evaluation of DrugScore. Journal of Medicinal Chemistry 45, 1967-1970.

Sotriffer, C.A., Winger, R.H., Liedl, K.R., Rode, B.M., and Varga, J.M. (1996) Comparative docking studies on ligand binding to the multispecific antibodies IgE-La2 and IgE-Lb4. Journal of Computer Aided Molecular Design 10, 305-320.

Stams, T., and Christianson, D.W. (2000) X-ray crystallographic studies of mammalian carbonic anhydrase isozymes. In Carbonic Anhydrase — New Horizons, Chegwidden, W.R., and Carter, N., Eds., Birkhäuser Verlag, pp. 159-174.

Stringer, J.L. (2000) A comparison of topiramate and acetazolamide on seizure duration and paired-pulse inhibition in the dentate gyrus of the rat. Epilepsy Research 40, 147-153.

Stubbs, M.T., Reyda, S., Dullweber, F., Moller, M., Klebe, G., Dorsch, D., Mederski, W.W., and Wurziger, H. (2002) pH-dependent binding modes observed in trypsin crystals: lessons for structure-based drug design. Chem-Biochem 3, 246-249.

Sugrue, M.F. (2000) Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Progress in Retinal and Eye Research 19, 87-112.

Supuran, C.T., and Scozzafava, A. (2000) Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opinion on Therapeutic Patents, 10, 575-600.

Supuran, C.T., and Scozzafava, A. (2002) Applications of carbonic anhydrase inhibitors and activators in therapy. Expert Opinion on Therapeutic Patents 12, 217-242.

Takeoka, M., Riviello, J.J., Jr., Pfeifer, H., and Thiele, E.A. (2002) Concomitant treatment with topiramate and ketogenic diet in pediatric epilepsy. Epilepsia 43, 1072-1075.

Taverna, S., Sancini, G., Mantegazza, M., Franceschetti, S., and Avanzini, G. (1999) Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate. Journal of Pharmacology and Experimental Therapeutics 288, 960-968.

Topliss, J.G. (1977) A manual method for applying the Hansch approach to drug design. Journal of Medicinal Chemistry 20, 463-469.

Tripp, B.C., Smith, K., and Ferry, J.G. (2001) Carbonic anhydrase: New insights for an ancient enzyme. Journal of Biological Chemistry 276, 48615-48618.

Vicker, N., Ho, Y., Robinson, J., Woo, L.L., Purohit, A., Reed, M.J., and Potter, B.V. (2003) Docking studies of sulphamate inhibitors of estrone sulphatase in human carbonic anhydrase II. Bioorganic and Medicinal Chemistry Letters 13, 863-865.

Watling, C.J., and Cairncross, J.G. (2002) Acetazolamide therapy for symptomatic plateau waves in patients with brain tumors. Report of three cases. Journal of Neurosurgery 97, 224-226.

Willis, A.M., Diehl, K.A., and Robbin, T.E. (2002) Advances in topical glaucoma therapy. Veterinary Ophthalmology 5, 9-17.

Zullino, D.F., Krenz, S., and Besson, J. (2003) AMPA blockade may be the mechanism underlying the efficacy of topiramate in PTSD. Journal of Clinical Psychiatry 64, 219-220.

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment